Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 1471 AL 1485

The synaptic marker neurogranin as a disease state biomarker in Alzheimer's disease: a systematic review and meta-analysis

Wang Z, Yang J, Zhu W, Tang Y, Jia J.

Int J Neurosci. 2022 Dec;132(12):1245-1253. doi: 10.1080/00207454.2021.1881087. Epub 2021 Feb 10.

A narrative review on the potential of tomato and lycopene for the prevention of Alzheimer's disease and other dementias

Ratto F, Franchini F, Musicco M, Caruso G, Di Santo SG.

Crit Rev Food Sci Nutr. 2022;62(18):4970-4981. doi: 10.1080/10408398.2021.1880363. Epub 2021 Feb 12.

Alzheimer's Dementia: The Emerging Role of Positron Emission Tomography

Tripathi SM, Murray AD.

Neuroscientist. 2022 Oct;28(5):507-519. doi: 10.1177/1073858421997035. Epub 2021 Mar 4.

Recent advances in pre-clinical diagnosis of Alzheimer's disease

Zhou J, Benoit M, Sharoar MG.

Metab Brain Dis. 2022 Aug;37(6):1703-1725. doi: 10.1007/s11011-021-00733-4. Epub 2021 Apr 26.

The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis

Anuradha U, Kumar A, Singh RK.

Neurol Sci. 2022 Jan;43(1):285-298. doi: 10.1007/s10072-021-05343-7. Epub 2021 May 25.

State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease

Hampel H, Shaw LM, Aisen P, Chen C, Lleó A, Iwatsubo T, Iwata A, Yamada M, Ikeuchi T, Jia J, Wang H, Teunissen CE, Peskind E, Blennow K, Cummings J, Vergallo A.

Alzheimers Dement. 2022 Jan;18(1):159-177. doi: 10.1002/alz.12372. Epub 2021 May 27.

Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney

Sexton CE, Anstey KJ, Baldacci F, Barnum CJ, Barron AM, Blennow K, Brodaty H, Burnham S, Elahi FM, Götz J, Jeon YH, Koronyo-Hamaoui M, Landau SM, Lautenschlager NT, Laws SM, Lipnicki DM, Lu H, Masters CL, Moyle W, Nakamura A, Pasinetti GM, Rao N, Rowe C, Sachdev PS, Schofield PR, Sigurdsson EM, Smith K, Srikanth V, Szoeke C, Tansey MG, Whitmer R, Wilcock D, Wong TY, Bain LJ, Carrillo MC.

Alzheimers Dement. 2022 Jan;18(1):178-190. doi: 10.1002/alz.12380. Epub 2021 May 31.

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial

Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, Whitlow CT, Hanson AJ, Friedman S, Register T, Leverenz JB, Craft S.

Alzheimers Dement. 2022 Mar;18(3):457-468. doi: 10.1002/alz.12421. Epub 2021 Jul 26.

Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline

Mielke MM, Aakre JA, Algeciras-Schimnich A, Proctor NK, Machulda MM, Eichenlaub U, Knopman DS, Vemuri P, Graff-Radford J, Jack CR Jr, Petersen RC, Dage JL.

Alzheimers Dement. 2022 Apr;18(4):602-611. doi: 10.1002/alz.12415. Epub 2021 Jul 26.

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

Mortby ME, Adler L, Agüera-Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, Padala PR, Politis A, Rosenberg PB, Siarkos K, Sultzer DL, Theleritis C; ISTAART NPS PIA.

Am J Geriatr Psychiatry. 2022 Feb;30(2):119-147. doi: 10.1016/j.jagp.2021.06.016. Epub 2021 Jul 1.

Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration

Ayyadevara S, Ganne A, Balasubramaniam M, Shmookler Reis RJ.

Metab Brain Dis. 2022 Jan;37(1):147-152. doi: 10.1007/s11011-021-00791-8. Epub 2021 Aug 4.

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease

Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2022 Apr;18(4):824-857. doi: 10.1002/alz.12422. Epub 2021 Sep 28.

Current directions in tau research: Highlights from Tau 2020

Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion JP, Buée L, Cacace AM, Chételat G, Citron M, DeVos SL, Diaz K, Feldman HH, Frost B, Goate AM, Gold M, Hyman B, Johnson K, Karch CM, Kerwin DR, Koroshetz WJ, Litvan I, Morris HR, Mummery CJ, Mutamba J, Patterson MC, Quiroz YT, Rabinovici GD, Rommel A, Shulman MB, Toledo-Sherman LM, Weninger S, Wildsmith KR, Worley SL, Carrillo MC.

Alzheimers Dement. 2022 May;18(5):988-1007. doi: 10.1002/alz.12452. Epub 2021 Sep 28.

Alzheimer's disease clinical trial update 2019-2021

Pleen J, Townley R.

J Neurol. 2022 Feb;269(2):1038-1051. doi: 10.1007/s00415-021-10790-5. Epub 2021 Oct 5.

Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial

Lin PY, Cheng C, Satyanarayanan SK, Chiu LT, Chien YC, Chuu CP, Lan TH, Su KP.

Brain Behav Immun. 2022 Jan;99:289-298. doi: 10.1016/j.bbi.2021.10.014. Epub 2021 Oct 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias